SBSteven M. Brunelli

Steven M. Brunelli

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Steven M. Brunelli has a total of 32 co-authors. Here are the top co-authors by number of shared publications:

  • Harold I. Feldman

    Renal-Electrolyte and Hypertension Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; †Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; and ‡Renal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

    4 shared publications
  • Katherine E. Lynch

    Renal-Electrolyte and Hypertension Division, University of Pennsylvania School of Medicine, Philadelphia, PA, USA

    3 shared publications
  • Dylan S. Small

    Department of Statistics and Data Science, University of Pennsylvania , 265 South 37th Street , Philadelphia, Pennsylvania 19104

    2 shared publications
  • Elizabeth D. Ankers

    Renal-Electrolyte and Hypertension Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; †Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; and ‡Renal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

    2 shared publications
  • Harold I. Feldman

    Patient-Centered Outcomes Research Institute, Washington, DC

    2 shared publications
  • Marshall M. Joffe

    Renal-Electrolyte and Hypertension Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; †Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; and ‡Renal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

    2 shared publications

Latest Publications

    • 1 January 2009
      • Vol. 41  (1) , 39-45

    A comparison of sodium phosphosoda purgative to polyethylene glycol bowel preparations prior to colonoscopy.

    by Steven M Brunelli, Harold I Feldman, Sherif M Latif, Meera Gupta, Mark G Weiner, James D Lewis

    Successful colonoscopy is contingent upon adequate bowel preparation, which is often achieved using either an oral sodium phosphate preparation or a polyethylene glycol-based preparation. Comparison of the relative performance of these two classes of agents has been assessed only in the context of clinical trials (and with mixed findings). However, efficacy measured in clinical trials often is not reflective of effectiveness in clinical practice. We undertook this analysis to determine the relative clinical effectiveness of oral sodium phosphosoda versus polyethylene glycol in clinical practice. Subjects (n=343) were selected from among patients receiving outpatient colonoscopy at our institution between January 2004 and February 2006. Demographic, biochemical, and comorbid disease data were abstracted from the electronic medical record. Colonoscopy preparation, indication, and preparation quality were abstracted from colonoscopy reports. As compared to subjects receiving polyethylene glycol, those receiving oral sodium phosphosoda had an adjusted odds ratio (OR) (95% confidence intervals [CIs]) for adequate/good/excellent bowel preparation quality of 2.23 (1.18--4.22) and an adjusted OR (95% CIs) for good/excellent bowel preparation of 2.24 (1.26--3.97). There was no interaction on the basis of colonoscopy indication. Oral sodium phosphate-based purgatives were associated with significantly better bowel preparation quality among outpatients at our center.


  • Open Access

    Association of Hemoglobin Variability and Mortality among Contemporary Incident Hemodialysis Patients

    by Steven M. Brunelli, Katherine E. Lynch, Elizabeth D. Ankers, Marshall M. Joffe, Wei Yang, Ravi I. Thadhani, Harold I. Feldman

    Background and objectives: Evidence exists that variability in hemoglobin may be an independent risk factor for mortality among hemodialysis patients. These observations were based on a 1996 cohort, a time when anemia management differed greatly from present. Design, settings, participants and measurements: A retrospective cohort study of patients incident to Fresenius Medical Care units between 2004 and 2005 (n = 6644). Hemoglobin variability (Hgb-Var) was defined for each subject as the residual SD of a linear regression model of time on hemoglobin. Results: The mean (SD) of Hgb-Var was 1.13 (0.55) g/dl. In the primary analysis, each g/dl increase of Hgb-Var was associated with an adjusted hazard ratio (95% confidence interval) for all-cause mortality of 1.11 (0.92 to 1.33). No significant interaction with Hgb-Var and mortality was found on the basis of age (P = 0.22), arterial disease (P = 0.45), Hgb slope (P = 0.68), or mean Hgb (P = 0.78). When Hgb-Var was defined by a regression model that included a quadratic term for time (enabling descriptions of curvilinear hemoglobin trajectories), model fit was greatly improved (P for difference versus prevalent hemodialysis patients.


  • Effects of l-Carnitine on Dialysis-Related Hypotension and Muscle Cramps: A Meta-analysis

    by Katherine E. Lynch, Harold I. Feldman, Jesse A. Berlin, James Flory, Christopher G. Rowan, Steven M. Brunelli


  • Association Between Long-term Blood Pressure Variability and Mortality Among Incident Hemodialysis Patients

    by Steven M. Brunelli, Ravi I. Thadhani, Katherine E. Lynch, Elizabeth D. Ankers, Marshall M. Joffe, Raymond Boston, Yuchaio Chang, Harold I. Feldman


  • Open Access

    Investigation of the association between oral sodium phosphate use and kidney injury

    by S. M. Brunelli, J. D. Lewis, K. E. Lynch, M. M. Joffe, M. Gupta, S. M. Latif, M. G. Weiner, H. I. Feldman


  • Extended Instrumental Variables Estimation for Overall Effects

    by Marshall M Joffe, Dylan Small, Thomas Ten Have, Steve Brunelli, Harold I Feldman

    We consider a method for extending instrumental variables methods in order to estimate the overall effect of a treatment or exposure. The approach is designed for settings in which the instrument influences both the treatment of interest and a secondary treatment also influenced by the primary treatment. We demonstrate that, while instrumental variables methods may be used to estimate the joint effects of the primary and secondary treatments, they cannot by themselves be used to estimate the overall effect of the primary treatment. However, instrumental variables methods may be used in conjunction with approaches for estimating the effect of the primary on the secondary treatment to estimate the overall effect of the primary treatment. We consider extending the proposed methods to deal with confounding of the effect of the instrument, mediation of the effect of the instrument by other variables, failure-time outcomes, and time-varying secondary treatments. We motivate our discussion by considering estimation of the overall effect of the type of vascular access among hemodialysis patients.


    • 1 January 2008
      • Vol. 4  (1) , artno4

    Extended Instrumental Variables Estimation for Overall Effects*

    by Marshall M. Joffe, Dylan Small, Thomas Ten Have, Steve Brunelli, Harold I. Feldman

    We consider a method for extending instrumental variables methods in order to estimate the overall effect of a treatment or exposure. The approach is designed for settings in which the instrument influences both the treatment of interest and a secondary treatment also influenced by the primary treatment. We demonstrate that, while instrumental variables methods may be used to estimate the joint effects of the primary and secondary treatments, they cannot by themselves be used to estimate the overall effect of the primary treatment. However, instrumental variables methods may be used in conjunction with approaches for estimating the effect of the primary on the secondary treatment to estimate the overall effect of the primary treatment. We consider extending the proposed methods to deal with confounding of the effect of the instrument, mediation of the effect of the instrument by other variables, failure-time outcomes, and time-varying secondary treatments. We motivate our discussion by considering estimation of the overall effect of the type of vascular access among hemodialysis patients.


  • Open Access

    Risk of Kidney Injury Following Oral Phosphosoda Bowel Preparations

    by Steven M. Brunelli, James D. Lewis, Meera Gupta, Sherif M. Latif, Mark G. Weiner, Harold I. Feldman


  • Open Access

    Hypophosphatemia

    by Steven M. Brunelli, Stanley Goldfarb

    Current evidence regarding the clinical consequences of hypophosphatemia is not straightforward. Given the potentially different implications of hypophosphatemia among various patient groups, this commentary touches on patients with low serum phosphate after acute hospitalization, those with chronic ambulatory hypophosphatemia, and those with hypophosphatemia in the setting of advanced renal disease. Finally, this commentary examines the evidence regarding how best to replete phosphorous in the hypophosphatemic patient.